GraceMed announces appointment of Dan Pawliw as Chief Executive Officer
Dan Pawliw headshot
TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- GraceMed, a leading consolidator in the plastic surgery, dermatology, and medical aesthetics industry, is pleased to announce the appointment of Dan Pawliw as its new Chief Executive Officer.
A highly respected leader in clinical healthcare services, Dan brings a proven track record of innovation, growth, and team building. Over the past decade, he played a pivotal role in shaping and expanding Medcan, transforming it into one of Canada's most prominent health and wellness brands. He also co-founded Akira Health, a leading virtual healthcare services platform, which served millions of patients and was later acquired by Telus Health. He previously held roles in investment banking at Goldman Sachs in New York and JP Morgan H&Q in San Francisco.
"Dan's leadership philosophy aligns with GraceMed's mission," said Dr. Douglas Grace, Founder and Chief Medical Officer of GraceMed. "His unwavering dedication to excellence in client care, forward-thinking approach to healthcare innovation, and deep appreciation for the incredible team behind it all will be instrumental in guiding GraceMed into its next chapter of growth."
GraceMed seamlessly integrates cutting-edge technology with industry-leading procedures and best-in-class medical expertise. The team of highly skilled practitioners is committed to delivering personalized, high-quality care, ensuring exceptional results that help patients both look and feel their best. Dan joins GraceMed at a pivotal moment, as the company continues to evolve and redefine aesthetic, surgical, and functional medicine care across Canada.
Dan Pawliw holds an MBA from Northwestern University and a Bachelor of Commerce from Queen's University.
About GraceMedGraceMed is a North American-based platform helping more and more patients realize their true self. As a leading consolidator in the plastic surgery, dermatology and medical aesthetics industry, GraceMed partners with leading physicians and medical providers to deliver exceptional patient outcomes and results. For more information, visit www.gracemed.com.
Media contact:Dale GagoCommunications and Marketing Business PartnerFengate Asset Managementdale.gago@fengate.com437 326 1473
A photo accompanying this announcement is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/c7591b3b-3b25-498a-af4f-3442eaadb7dcErrore nel recupero dei dati
Effettua l'accesso per consultare il tuo portafoglio
Errore nel recupero dei dati
Errore nel recupero dei dati
Errore nel recupero dei dati
Errore nel recupero dei dati
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
National Fuel Increases Dividend Rate for 55th Consecutive Year
WILLIAMSVILLE, N.Y., June 12, 2025 (GLOBE NEWSWIRE) -- Today, the National Fuel Gas Company ("National Fuel" or the "Company") (NYSE: NFG) Board of Directors approved a 3.9% increase in the dividend on the Company's common stock, raising the quarterly rate from 51.5 cents per share as approved in June 2024 to 53.5 cents per share for an annual rate of $2.14 per share. National Fuel has paid dividends for 123 consecutive years and has increased its annual dividend for 55 straight years. This dividend is payable July 15, 2025, to stockholders of record at the close of business on June 30, 2025. The Company has approximately 90.4 million shares of common stock outstanding. It has no preferred stock outstanding. National Fuel is a diversified energy company headquartered in Western New York that operates an integrated collection of natural gas assets across four business segments: Exploration & Production, Pipeline & Storage, Gathering, and Utility. Additional information about National Fuel is available at CONTACT: Investor Contact: Natalie Fischer | 716-857-7315 Media Contact: Karen Merkel | 716-857-7654Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
33 minutes ago
- Yahoo
Robotic Pet Company Tombot Secures $6.1M Series A Funding to Support Groundbreaking Health and Senior Care Product Line
LOS ANGELES, June 12, 2025--(BUSINESS WIRE)--Tombot, the robotics company that earned widespread acclaim at CES earlier this year for its lifelike robotic puppy, Jennie, announced today the successful close—and oversubscription—of its $6.1 million Series A funding round. "Tombot is entering a high-demand, underserved market at the intersection of mental health and assistive technology," said Tombot CEO and Co-Founder Tom Stevens. "Over 300 million seniors around the world with dementia and mild cognitive impairment are unable to care for a live animal at a time when they need the companionship of a pet more than ever. Millions of other individuals suffering from mental health adversities are in a similar predicament." With artistic design by Jim Henson's Creature Shop, and developed with the guidance of clinical experts, patients, and their families, Jennie provides many of the health benefits associated with live animal ownership, such as reduced stress and loneliness. Jennie will be used in private homes, assisted living and memory care communities, and other settings where live animals are not always safe or practical. Covered with sensors to respond to touch, voice commands, movement, and other sensory inputs, Jennie is rechargeable, fully cleanable, and comes with an optional caregiver app to customize behaviors and ease the burden of caregiving. With participation from both new and existing investors, the funding round was led by Caduceus Capital Partners, a Nashville-based team of veteran healthcare investors with a primary emphasis on accelerating growth of early-stage digital health startups. "We identified the growing need for robotic companions several years ago and believe the market is now on the brink of exponential expansion," said Dave Vreeland, senior managing partner, Caduceus Capital Partners. "By 2030, the U.S. is projected to have 73 million seniors – an aging population that will increasingly face challenges related to loneliness, companionship, and chronic disease management. These issues are rapidly surpassing the capacity of human caregivers alone. Tombot is uniquely positioned to lead this emerging sector and drive widespread adoption of robotic companions." "This investment will be rocket fuel for Tombot," said Stevens. "We are most appreciative of our company's Board of Directors for their ongoing guidance, and are especially grateful to Caduceus for recognizing and supporting Tombot's mission of creating robotic animals that transform the daily lives of individuals, families, and communities facing health adversities." According to Stevens, this milestone investment will be used to expand Tombot's team, finalize engineering, complete regulatory and safety certifications, and prepare its first robotic pet for customer shipments to its more than 16,000 pre-order and waitlist customers. About Tombot Tombot, Inc., established in 2017, designs realistic robotic companion animals for individuals unable to safely or practically care for a live animal. After Tom Stevens' own mother's progressive dementia necessitated the rehoming of her beloved pet dog for safety reasons, Tom launched Tombot. Tombot's flagship product, Jennie, was designed specifically to treat the Behavioral and Psychological Symptoms of Dementia (BPSD). The Tombot founding team built a prior startup into one of the world's largest legal automation companies and was successfully acquired. View source version on Contacts Media Contacts: Brotman•Winter•Fried Consulting Laura Runcielaura@ (201)707-9372 Steve Winterswinter@ (202) 468-8100
Yahoo
36 minutes ago
- Yahoo
Navigating Transformative Shifts: How Sustainability Drives Innovation in the Medical Device Packaging Sector
The medical device packaging market offers opportunities through sustainability-focused material innovation, digital traceability for enhanced supply chain transparency, and localization of production to mitigate U.S. tariff impacts. Companies can capitalize by integrating eco-friendly materials, adopting IoT-enabled solutions, and diversifying sourcing strategies. Medical Device Packaging Market Dublin, June 12, 2025 (GLOBE NEWSWIRE) -- The "Medical Device Packaging Market by Type, Material Type, Sterilization Method Compatibility, Packaging Level, Packaging Formats, Device Type, Packaging Type, Application, Distribution Channel, End User - Global Forecast to 2030" report has been added to offering. The evolution in the medical device packaging market is set to continue its robust growth trajectory, transitioning from USD 39.96 billion in 2024 to an anticipated USD 58.55 billion by 2030, driven by a steady CAGR of 6.57%. Pioneering the Evolution of Medical Device Packaging The medical device packaging sector occupies a critical junction of innovation and regulatory compliance. As device designs advance and sterilization standards tighten, packaging has emerged as a critical strategic tool rather than a mere logistical necessity. Companies are challenged to reconcile protective efficacy with sustainability imperatives, cost-efficiency, and user-centric designs. Material science innovations must meet compliance standards while adapting to fluctuating global supply chain demands. This report synthesizes market intelligence and expert analysis to guide stakeholders in navigating these transformative shifts and securing a competitive market advantage. Navigating Transformative Shifts in the Packaging Landscape Technological advancements, regulatory shifts, and sustainability demands are reshaping the medical device packaging landscape. Sustainability now dictates material selection and recycling processes, with innovations in materials like advanced polymers and Tyvek optimizing both barrier performance and environmental impact. Regulatory trends are imposing harmonized design standards across sterilization methods such as dry heat, electron beam, and gamma radiation. The integration of digital identification enhances supply chain transparency, reinforcing both patient safety and authenticity. Assessing the 2025 United States Tariff Impact on Packaging The 2025 U.S. tariff modifications impose new challenges on medical device packaging supply chains, particularly affecting cost structures linked to materials like aluminum foil, glass, and plastics. This escalation is profound for products necessitating high-precision barrier properties. To mitigate the ensuing complexities and margin pressures, companies are recalibrating sourcing strategies and exploring regional manufacturing solutions. Key Takeaways from This Report Segmentation insights reveal a diverse packaging landscape, from ampoules for injectables to customizable unit-dose sachets for home healthcare. Material innovation remains key, with aluminum and Tyvek representing critical success areas. An understanding of regional dynamics facilitates targeted strategic decisions, identifying varied growth drivers in key territories such as North America, Europe, and the rapidly evolving Asia-Pacific region. Leading companies are leveraging integrated material science and digital innovations, emphasizing end-to-end solutions that ensure compliance and sustainability while enhancing patient safety. Decoding Regional Dynamics in Medical Device Packaging Markets Geographic analysis reveals unique market drivers across major regions. In the Americas, the rise of ambulatory surgical centers boosts demand for sterile packaging, while Europe's regulatory landscape prioritizes recyclability and biodegradability. Asia-Pacific's dynamic growth is marked by rising investments in healthcare infrastructure and intense demand for both rigid and flexible packaging. Spotlight on Leading Innovators Shaping Industry Trajectory Key industry players like West Pharmaceutical Services and Amcor PLC are leading through innovative materials and strategic partnerships. Such collaborations enhance competitive positioning by integrating advanced solutions across sterilization, sustainability, and digital traceability. By building comprehensive packaging ecosystems, these companies are achieving a blend of regulatory intelligence and material expertise. Strategic Recommendations to Strengthen Market Positioning Organizations should foster sustainability by embedding recycled content and enhancing circularity. Digital platforms for traceability will enhance product authentication and recall mechanisms. Near-shoring and dual-sourcing strategies will aid in tariff resilience, while detailed market segmentation will help align product offerings with targeted end-user needs. Synthesizing Core Findings for Actionable Intelligence This executive summary is a distilled guide to the medical device packaging industry's key trends and strategic imperatives. It highlights sustainability and digital traceability as critical factors shaping the future, alongside significant tariff impacts. By leveraging the strategic recommendations, companies can secure a robust market position while navigating regulatory complexities with data-driven insights. Companies Featured The companies profiled in this Medical Device Packaging market report include: 3M Company Amcor Limited AptarGroup Inc. Berry Global Inc. Coveris Management DuPont de Nemours, Inc. EPL Limited Huhtamaki Oyj Johnson & Johnson Services, Inc. Mitsubishi Chemical Holdings Corporation Oliver Healthcare Packaging Ostium Group Placon Corporation Riverside Medical Packaging Company Limited STERIS Group Toppan Printing Co., Ltd. West Pharmaceutical Services, Inc. WestRock Company Wipak Group Key Attributes: Report Attribute Details No. of Pages 191 Forecast Period 2025 - 2030 Estimated Market Value (USD) in 2025 $42.57 Billion Forecasted Market Value (USD) by 2030 $58.55 Billion Compound Annual Growth Rate 6.5% Regions Covered Global Key Topics Covered: Executive Summary Current Landscape and Historical Evolution of Medical Device Packaging Consumer Drivers, Product Strategy Trade-offs, and Regulatory Dynamics Lifecycle Stages, IP Insights, and Strategic Go-to-Market Roadmap Phased Market Outlook, Growth Strategies, and Emerging Trends Market Overview Unpacking the Medical Device Packaging Market's Economic Significance and Growth Catalysts Regional Dynamics Shaping Global Medical Device Packaging Adoption Recent Innovations and Collaborations Driving Packaging Advancements Market Sizing & Forecasting Market Dynamics Smart packaging integration with IoT sensors for real-time device condition monitoring and compliance tracking Adoption of sustainable biodegradable barrier films boosts eco-friendly sterile device packaging efficiency AI-driven predictive packaging testing accelerates regulatory approval timelines for innovative medical devices RFID-enabled tamper-evident closures enhance supply chain traceability and security in surgical kit distribution Customization of on-demand 3D printed packaging solutions enhances complex instrument protection and scalability Advanced antimicrobial surface coatings in medical packaging reduce contamination risk during global transport Nanocomposite materials improve moisture and gas barrier properties in implantable device packaging applications Integration of blockchain-based provenance tracking for end-to-end packaging transparency and authenticity Rise of ultraviolet-activated antimicrobial inner liners for on-demand decontamination during transport Emergence of custom-fit vacuum skin packaging solutions securing irregularly shaped surgical instruments Market Insights Porter's Five Forces Analysis PESTLE Analysis Cumulative Impact of United States Tariffs 2025 Landmark Tariffs Reshaping the US Market 2023-2025 Evolution of US Tariff Policy and Its Economic Rationale 2018-2025 Tariffs as a Driver of Inflation in the Global Economy Escalation of Reciprocal Tariffs and New Trade Wars Economic and Political Fallout in Key Trading Partners Structural Shifts in US Industry and Consumer Impact Policy Pathways to Alleviate Tariff-Induced Strain Medical Device Packaging Market, by Type Ampoules & Vials Bags & Pouches Boxes Clamshell & Blister Packs Containers Labels & Cards Sterile Barrier Systems Trays Tubes Wraps Medical Device Packaging Market, by Material Type Aluminum Foil Glass Paper & Paperboard Plastics Silicone Tyvek Medical Device Packaging Market, by Sterilization Method Compatibility Dry Heat Sterilization Electron Beam (E-beam) Sterilization Ethylene Oxide (EtO) Sterilization Gamma Radiation Sterilization Steam Sterilization Medical Device Packaging Market, by Packaging Level Primary Packaging Secondary Packaging Tertiary Packaging Medical Device Packaging Market, by Packaging Formats Flexible Formats Rigid Formats Medical Device Packaging Market, by Device Type Dental Devices Diagnostic Equipment Electro-medical Devices Home Healthcare Devices Implants IV Equipment Respiratory Devices Surgical Instruments Medical Device Packaging Market, by Packaging Type Flexible Packaging Rigid Packaging Medical Device Packaging Market, by Application Non-Sterile Packaging Sterile Packaging Medical Device Packaging Market, by Distribution Channel Offline Online Medical Device Packaging Market, by End User Ambulatory Surgical Centers Clinics Hospitals Pharmaceutical Companies Competitive Landscape Market Share Analysis, 2024 FPNV Positioning Matrix, 2024 Competitive Analysis For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Medical Device Packaging Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
